Found 141 articles
Janssen to Present Latest Research from Robust Blood Cancer and Cardiovascular Disease Portfolios at this Year's American Society of Hematology Annual Meeting
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today 46 company-sponsored and more than 30 investigator-led abstracts will be presented at the American Society of Hematology (ASH) Annual Meeting in Orlando, Florida, December 7-10.
TYMLOS U.S. net sales grew to $47M and is capturing half of anabolic new patient starts
Growth Driven By the Addition of coflex® Interlaminar Stabilization® Device and Solid Contribution from OEM Franchise
With one internet search, a patient can find a host of information and marketing materials touting the purported benefits of laser surgery.
NuVasive Specialized Orthopedics Reaches 10,000 Nail Implant Milestone of the Precice® System for Limb Lengthening
NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced a milestone of 10,000 implants of the Precice® system for conditions related to limb lengthening and reconstruction from NuVasive Specialized Orthopedics™
Lysogene (Paris:LYS) (FR0013233475 – LYS), a leading, Phase 3, biopharmaceutical company pioneering gene therapy technologies to treat central nervous system (CNS) diseases, today announced the formation of a Scientific Advisory Board (SAB) comprised of world-leading experts in gene therapy discovery and development
Providing access to proton therapy treatment for cancer patients in the tri-state area, the New York Proton Center held a ribbon cutting event yesterday to commemorate the opening of the facility.
Hong Kong is known around the world for its financial might, iconic skyline and international outlook. But it might not be long before the city is known for something totally outside its traditional realm: cutting-edge healthcare solutions.
OSSIO Announces U.S. Launch and First Commercial Use of the New OSSIOfiberTM Bone Pin for Hammertoe Correction
New Category Offers Surgeons Strong, Secure Fixation and “Biologically Friendly” Approach to Restoring Patient Stability and Mobility with No Permanent Implant Left Behind
Navitor Pharmaceuticals Announces Peer-Reviewed Publication in Journal of Clinical Investigation Highlighting Rapid Antidepressant Effects of NV-5138
Navitor Pharmaceuticals, Inc., the leader in the development of mTORC1-targeted therapeutics designed to help patients live longer and healthier lives, announced today the publication of a peer-reviewed article in the Journal of Clinical Investigation, highlighting the rapid and long-lasting antidepressant effects of NV-5138 in behavioral models of depression and treatment response.
Updated NASS Position on Lumbar Artificial Disc Replacement Matches Centinel Spine's prodisc® L Indications
Centinel Spine®, LLC announced that the North American Spine Society has issued an updated coverage policy recommendation for lumbar artificial disc replacement.
On March 15-17, 2019 Los Angeles to host the World's First Brain Expo for general public and the largest Neurotech (Brain and Spine) Investment Forum, the 16th Annual World Brain Mapping Conference at the LA Convention Center and the Brain Mapping Foundation Black-Tie Gala Fundraiser at the Intercontinental Hotel in Downtown LA
In the news release, Positive Payor Policy Covering coflex® by AmeriHealth Caritas for the Surgical Treatment of Lumbar Spinal Stenosis, issued Nov. 27, 2018 by Paradigm Spine, LLC over PR Newswire, we are advised by the company that the fourth and fifth paragraphs have been updated to clarify limitations on the coverage policy.
In the news release, Positive Payor Policy Covering coflex® by Select Health of South Carolina for the Surgical Treatment of Lumbar Spinal Stenosis, issued Dec. 11, 2018 by Paradigm Spine, LLC over PR Newswire, we are advised by the company that the fourth and fifth paragraphs have been updated to clarify limitations on the coverage policy.
New Bio-Integrative Orthopedic Fixation Material Provides Unprecedented Combination of Mechanical Strength and Natural Bone Healing in a Non-Permanent Implant
Janssen Submits Supplemental New Drug Application (sNDA) to FDA for XARELTO® (rivaroxaban) to Prevent Venous Thromboembolism (VTE) in Acute Medically Ill Patients
he Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a supplemental New Drug Application (sNDA) for XARELTO® (rivaroxaban) to the U.S. Food and Drug Administration (FDA) for the prevention of venous thromboembolism (VTE), or blood clots, in medically ill patients.
Positive Payor Policy Covering coflex® by Select Health of South Carolina for the Surgical Treatment of Lumbar Spinal Stenosis
Paradigm Spine, LLC today announced issuance of a Select Health of South Carolina Clinical Policy for the exclusive coverage of the coflex
Subsidiaries Align as Unified Brand to Deliver Better Outcomes for All
Positive Payor Policy Covering coflex® by AmeriHealth Caritas for the Surgical Treatment of Lumbar Spinal Stenosis
Coverage policy issued by AmeriHealth Caritas
Three American scientists are included among the winners of the International Awards given by the Sheikh Hamdan bin Rashid al Maktoum Award for Medical Sciences, according to an official announcement that was given recently in Dubai.